The prevalence of cancer in patients with Multiple Sclerosis (MS) who were under treatment with Natalizumab (Tysabri): A systematic review and meta-analysis
Background: To determine the pooled prevalence of cancer in subjects with multiple sclerosis (MS) who received Natalizumab. Methods: Two researchers systematically searched PubMed, Scopus, EMBASE, Web of Science, google scholar, and gray literature including references of the included studies. The s...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Серія: | International Journal of Preventive Medicine |
| Предмети: | |
| Онлайн доступ: | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2023;volume=14;issue=1;spage=114;epage=114;aulast=Nasirzadeh |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|